Abeona Therapeutics Inc.
ABEO
$5.75
-$0.15-2.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 9.94M | 33.31M | 485.00K | 224.00K | 7.21M |
| Gross Profit | -9.94M | -33.31M | -485.00K | -224.00K | -7.21M |
| SG&A Expenses | 9.79M | 7.68M | 6.40M | 8.65M | 7.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.73M | 16.67M | 15.35M | 17.86M | 14.33M |
| Operating Income | -19.73M | -16.67M | -15.35M | -17.86M | -14.33M |
| Income Before Tax | -12.03M | -9.29M | -30.27M | 7.41M | -31.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.03M | -9.29M | -30.27M | 7.41M | -31.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.03M | -9.29M | -30.27M | 7.41M | -31.58M |
| EBIT | -19.73M | -16.67M | -15.35M | -17.86M | -14.33M |
| EBITDA | -19.19M | -16.13M | -14.86M | -17.38M | -13.84M |
| EPS Basic | -0.24 | -0.19 | -0.63 | 0.19 | -1.16 |
| Normalized Basic EPS | -0.15 | -0.12 | -0.39 | 0.12 | -0.72 |
| EPS Diluted | -0.24 | -0.19 | -0.63 | -0.26 | -1.16 |
| Normalized Diluted EPS | -0.15 | -0.12 | -0.39 | 0.09 | -0.72 |
| Average Basic Shares Outstanding | 49.78M | 48.68M | 48.08M | 40.01M | 27.32M |
| Average Diluted Shares Outstanding | 49.78M | 48.68M | 48.08M | 51.23M | 27.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |